Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Patzold

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1994
L-Dopa improves colour vision in Parkinson's diseaseT Büttner, W Kuhn, T Patzold, et al.
Clinical Neuropharmacology|October 1, 1995
Color vision in Parkinson's disease: missing influence of amantadine sulphateT Büttner, W Kuhn, T Müller, et al.
Journal of Neuroimmunology|December 10, 1998
Immunomodulatory effects of interferon-beta-1b in vivo: induction of the expression of transforming growth factor-beta1 and its receptor type IIL M Ossege, E Sindern, T Patzold, et al.
International Immunopharmacology|June 16, 2001
Immunomodulatory effects of interferon-beta-1b in patients with multiple sclerosisL M Ossege, E Sindern, T Patzold, et al.
Journal of Neurology|December 5, 1998
The soluble 60-kDa tumour necrosis factor receptor: no difference found between patients with relapsing-remitting multiple sclerosis and controls: increasing levels are associated with the recovery from Guillain-Barré syndromeT Patzold, E Sindern, L Ossege-Pohle, et al.
Clinical Neurology and Neurosurgery|August 23, 2001
Respiratory monitoring in neuromuscular disease - capnography as an additional tool?S Kotterba, T Patzold, J P Malin, et al.
Neurology|February 1, 1995
Distorted color discrimination in 'de novo' parkinsonian patientsT Büttner, W Kuhn, T Müller, et al.
Acta Neurologica Scandinavica|March 12, 2002
Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosisT Patzold, M Schwengelbeck, L-M Ossege, et al.
Neurology|May 5, 1999
Phenotypic variability in rippling muscle diseaseM Vorgerd, H Bolz, T Patzold, et al.
Acta Neurologica Scandinavica|August 9, 2001
Differential release of beta-chemokines in serum and CSF of patients with relapsing-remitting multiple sclerosisE Sindern, Y Niederkinkhaus, M Henschel, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1994
L-Dopa improves colour vision in Parkinson's diseaseT Büttner, W Kuhn, T Patzold, et al.
Clinical Neuropharmacology|October 1, 1995
Color vision in Parkinson's disease: missing influence of amantadine sulphateT Büttner, W Kuhn, T Müller, et al.
Journal of Neuroimmunology|December 10, 1998
Immunomodulatory effects of interferon-beta-1b in vivo: induction of the expression of transforming growth factor-beta1 and its receptor type IIL M Ossege, E Sindern, T Patzold, et al.
International Immunopharmacology|June 16, 2001
Immunomodulatory effects of interferon-beta-1b in patients with multiple sclerosisL M Ossege, E Sindern, T Patzold, et al.
Journal of Neurology|December 5, 1998
The soluble 60-kDa tumour necrosis factor receptor: no difference found between patients with relapsing-remitting multiple sclerosis and controls: increasing levels are associated with the recovery from Guillain-Barré syndromeT Patzold, E Sindern, L Ossege-Pohle, et al.
Clinical Neurology and Neurosurgery|August 23, 2001
Respiratory monitoring in neuromuscular disease - capnography as an additional tool?S Kotterba, T Patzold, J P Malin, et al.
Neurology|February 1, 1995
Distorted color discrimination in 'de novo' parkinsonian patientsT Büttner, W Kuhn, T Müller, et al.
Acta Neurologica Scandinavica|March 12, 2002
Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosisT Patzold, M Schwengelbeck, L-M Ossege, et al.
Neurology|May 5, 1999
Phenotypic variability in rippling muscle diseaseM Vorgerd, H Bolz, T Patzold, et al.
Acta Neurologica Scandinavica|August 9, 2001
Differential release of beta-chemokines in serum and CSF of patients with relapsing-remitting multiple sclerosisE Sindern, Y Niederkinkhaus, M Henschel, et al.
Pageof 2